John Foy & Associates has announced Madilyn Abor as the winner of its 2025 Strong Arm Leukemia Scholarship. The $1,000 award will support Abor during her final semester at Baylor University, where she is completing a Bachelor of Science in Public Health.
Abor's journey began with an acute lymphocytic leukemia diagnosis at age nine. Her intensive treatment led to severe complications including septic shock, organ failure, and blood clots around her heart. Despite these challenges, she recovered and now dedicates herself to supporting children facing similar medical battles.
In her scholarship essay, Abor described how her experience with ALL inspired her career path toward becoming a pediatric oncology physician assistant. She expressed her commitment to "stand beside children who need someone to help them see their own strength, and to ensure they know their battles do not define them." Abor has already begun this work as a camp counselor with Camp John Mark.
The legal firm was deeply moved by Abor's story of survival and determination. John Foy & Associates hopes the financial support will ease her final semester as she prepares for graduate education. After graduation, Abor plans to work as a medical assistant for one year before entering a physician assistant program.
Students interested in future scholarship opportunities can learn more about the program's terms and qualifying criteria at https://www.johnfoy.com/scholarships/strong-arm-leukemia-scholarship/. The scholarship represents one way the firm supports community members beyond its legal services.
For business and technology leaders, this announcement highlights how professional service firms are expanding their community impact through targeted educational support. Scholarship programs like this one demonstrate how companies can leverage their resources to address specific societal needs while fostering future professionals in critical healthcare fields.
The selection of a public health student focused on pediatric oncology reflects growing recognition of the intersection between healthcare delivery, patient advocacy, and community support systems. As healthcare technology advances, professionals like Abor who combine medical expertise with personal understanding of patient experiences will be increasingly valuable in creating more empathetic and effective care models.
For the healthcare industry, stories like Abor's underscore the importance of supporting survivors who return to the medical field as providers. Their unique perspectives can drive innovation in patient-centered care approaches and improve outcomes for children facing serious illnesses. The scholarship investment in Abor's education represents a strategic contribution to developing healthcare professionals who understand both the clinical and human dimensions of pediatric oncology.
